TECHNOLAS 217A EXCIMER LASER SYSTEM

Excimer Laser System

FDA Premarket Approval P990027 S013

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for software changes introduced in software version 4. 23a that affected the error message displays during the conditioning, energy verification, andtreatment phases. The device, as modified, will be marketed under the trade nametechnolas t217z zyoptix laser system for personalized vision correction and is indicated for wavefront-guided laser assisted in-situ keratomileusis (lasik) treatments for the reductionor elimination of myopia with sphere up to -7. 00d and cylinder up to -3. 00d and mrse

DeviceTECHNOLAS 217A EXCIMER LASER SYSTEM
Classification NameExcimer Laser System
Generic NameExcimer Laser System
ApplicantTECHNOLAS PERFECT VISION GMBH
Date Received2009-10-01
Decision Date2009-11-04
PMAP990027
SupplementS013
Product CodeLZS
Advisory CommitteeOphthalmic
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address TECHNOLAS PERFECT VISION GMBH messerschmittstr 1 + 3 munchen 80992

Supplemental Filings

Supplement NumberDateSupplement Type
P990027Original Filing
S020 2015-10-07 30-day Notice
S019 2014-01-31 30-day Notice
S018 2012-05-01 Normal 180 Day Track
S017 2012-04-26 Real-time Process
S016 2010-09-17 135 Review Track For 30-day Notice
S015 2010-06-29 Normal 180 Day Track
S014
S013 2009-10-01 Real-time Process
S012 2009-05-15 Normal 180 Day Track No User Fee
S011 2008-09-03 Normal 180 Day Track
S010 2008-08-11 Normal 180 Day Track
S009 2006-12-19 Normal 180 Day Track
S008
S007 2004-09-10 Normal 180 Day Track
S006 2002-07-18 Panel Track
S005 2002-01-31 Normal 180 Day Track
S004 2001-12-14 Panel Track
S003 2001-04-27 Normal 180 Day Track
S002 2000-11-24 Panel Track
S001 2000-10-13 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.